OpportunityTitle: Improving HIV Prevention and Treatment Outcomes Among HIV-Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient-centered HIV Care
AdditionalInformationOnEligibility: 1. Eligible Applicants:    &#149;American Indian/Alaska Native tribal governments (federally recognized or state-recognized)  &#149;American Indian/Alaska native tribally designated organizations  &#149;Alaska Native health corporations  &#149;Colleges  &#149;Community-based organizations  &#149;Faith-based organizations  &#149;For-profit organizations (other than small business)  &#149;Hospitals  &#149;Nonprofit with 501C3 IRS status (other than institution of higher education)  &#149;Nonprofit without 501C3 IRS status (other than institution of higher education)  &#149;Political subdivisions of States (in consultation with States)  &#149;Research institutions (that will perform activities deemed as non-research)  &#149;Small, minority, and women-owned businesses  &#149;State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) .   &#149;Tribal epidemiology centers  &#149;Universities  &#149;Urban Indian health organizations
Description: In the last 20 years, care of persons infected with human immunodeficiency virus (HIV) has transitioned from treatment of an acute illness to comprehensive management of a chronic infection accompanied by a number of co-morbidities (Pallella FJ et al., 2006). Historically, HIV-infected patients were referred to infectious disease specialists, a model of care designed to meet patients&#146; acute illness needs. More effective therapy has led to significant reductions in HIV-associated morbidity and mortality. However, providers increasingly face challenges providing HIV care stemming from long-term management of HIV infection, other co-morbidities, side effects associated with antiretroviral therapy (ART), drug interactions, and increased risk of age-associated non-AIDS-related morbidity and mortality (Deeks S, 2009; Harrison KM et al., 2010).
GrantorContactEmailDescription: pgotim@cdc.gov
GrantorContactText: Center for Disease Control and Prevention (CDC0 Procurement and Grants Office  (PGO) &lt;br/&gt;Phone 770-488-2700